News & Views
CambReg Partner with Leading Indian Based CRO
Dec 18 2009
Cambridge Regulatory Services (CambReg) has formed a strategic alliance with SIRO Clinpharm, a leading global Indian based Clinical Research Organisation to provide pharma companies in both Asia and Europe
with both regulatory expertise and ability to conduct fast paced trials, according to the companies.
“This partnership will provide European pharma companies with increased confidence in accessing cost effective clinical trial solutions, hence introducing new clients to SIRO. In return SIRO will have the benefit of offering
regulatory expertise through CamReg,” commented Karen James, Managing Director of Cambridge Regulatory Services.
"Our alliance with CambReg would go a long way in helping small and mid-sized companies cut through the regulatory maze in Europe" said Dr Chetan Tamhankar, Chief Operating Officer of SIRO Clinpharm.
"This alliance builds on the strength of our European clinical trial operations and allows us to offer greater value to our clients." he added.
The new alliance will offer full regulatory services to pharma companies wishing to register human medicines, including new small molecule or biotech entities, Biologics, Herbals and Generics.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia